Prof. Dr.

Prof. Dr.

Ricarda Diem

Contact
Address
Department of Neurology
Medical Faculty, Heidelberg University
Im Neuenheimer Feld 400
69120 Heidelberg
Phone
+49 (0) 6221-5637774
eMail
Ricarda.diem@med.uni-heidelberg.de

www.klinikum.uni-heidelberg.de/Diem.123836.0.html

www.uni-heidelberg.de/izn/researchgroups/diem

www.academia-net.de
Scientific vita
Key Publications
2016-present
Spokesperson of the DFG-funded Research Unit FOR 2289
2011-present
Attending neurologist and leader of multiple sclerosis research group, Department of Neurology, University Clinic Heidelberg
2011-present
Leader of the medical education program Heidelberg (HeiCuMed) Neurosciences
2017
Offer of a W3 full professorship at the University of Münster (declined 07/17)
2007-2011
Attending neurologist and leader of multiple sclerosis research group and outpatient clinic, Department of Neurology, University of the Saarland
2009
Professor of Neurology
2003-2007
Junior research group leader, Department of Neurology, University of Göttingen
2006
Lecturer for Neurology (“Habilitation”)
2005
Board certification in Neurology
2001-2003
Postdoctoral position, Department of Neurology, University of Göttingen
1999-2001
Postdoctoral position, Department of Neurology, University of Tübingen
1997-1999
Medical resident, Department of Neurology, University of Würzburg
1996
License to practice medicine, Johannes-Gutenberg-University Mainz
1996
Medical Degree, Department of Pharmacology, University of Mainz

University Clinic Heidelberg
2007 - 2011
Attending neurologist and leader of multiple sclerosis research group and outpatient clinic, Department of Neurology, University of the Saarland
2003 – 2007
Junior Research group leader, Department of Neurology, University of Göttingen
2001 – 2003
Postdoctoral Position, Department of Neurology, University of Göttingen
1999 – 2001
Postdoctoral Position, Department of Neurology, University of Tübingen
1997 - 1999
Medical resident, Department of Neurology, University of Würzburg
1996
License to practice medicine, Johannes-Gutenberg-University Mainz
1996
Medical Degree, Department of Pharmacology, University of Mainz

Stoijc A, Bojecevski J, Williams SK, Diem R, Fairless R (2018) Early nodal and paranodal disruption in autoimmune optic neuritis. J Neuropathol Exp Neurol doi:10.10.93/jnen/nly011[epub ahead of print].

Diem R, Molnar F, Beisse F, Gross N, Drüschler K, Heinrich SP, Joachimsen L, Rauer S, Pielen A, Sühs KW, Linker RA, Huchzermeyer C, Albrecht P, Hassenstein A, Aktas O, Guthof T, Tonagel F, Kernstock C, Hartmann K, Kümpfel T, Hein K, van Oterendorp C, Grotejohann B, Ihorst G, Maurer J, Müller M, Volkmann M, Wildemann B, Platten M, Wick W, Heesen C, Schiefer U, Wolf S, Lagreze WA (2016) Treatment of optic neuritis with erythropoietin (TONE): a randomized, double-blind, placebo-controlled trial – study protocol. BMJ Open 6(3):e010953.

Sühs KW, Fairless R, Williams SK, Heine K, Cavalie A, Diem R (2014) N-methyl-D-aspartate receptor blockade is neuroprotective in experimental autoimmune optic neuritis. J Neuropathol Exp Neurol 73:507-18.

Davies AL, Desai RA, Bloomfield PS, McIntosh PR, Chapple KJ, Linington C, Fairless R, Diem R, Kasti M, Murphy MP, Smith KJ (2013) Neurological deficits caused by tissue hypoxia in neuroinflammatory disease. Ann Neurol 74:815–825.

Fairless R, Williams SK, Hoffmann D, Stojic A, Hochmeister S, Schmitz F, Storch MK, Diem R (2012) Preclinical retinal neurodegeneration in a model of multiple sclerosis. J Neurosci 32:5585-97.

Sühs KW, Hein K, Sättler MB, Görlitz A, Ciupka C, Scholz K, Käsmann-Kellner B, Papanagiotou P, Schäffler N, Restemeyer C, Bittersohl D, Hassenstein A, Seitz B, Reith W, Fassbender K, Hilgers R, Heesen C, Bähr M, Diem R (2012) A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol 72:199-210.

Gadjanski I, Boretius S, Williams SK, Lingor P, Knöferle J, Sättler MB, Fairless R, Hochmeister S, Sühs KW, Michaelis T, Frahm J, Storch MK, Bähr M, Diem R (2009) Role of N-type voltage-dependent calcium channels in autoimmune optic neuritis. Ann Neurol 66:81-93.

Diem R, Sättler MB, Merkler D, Demmer I, Maier K, Stadelmann C, Ehrenreich H, Bähr M (2005) Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 128:375-385.

Sättler MB, Merkler D, Maier K, Stadelmann C, Ehrenreich H, Bähr M, Diem R (2004) Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ 11 Suppl 2: S181-92.

Diem R, Hobom M, Maier K, Weissert R, Storch MK, Meyer R, Bähr M (2003) Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci 23:6993-7000.
Additional Information
2017-present
Elected member of the German Neuroscience Society’s Board and spokesperson of its section “Translational Neuroscience”
2016
“My Lab” Award of the Gemeinnützige Hertie-Stiftung
2006
Scientist’s Award (“Habilitationspreis”), University of Göttingen
2005
Sobek Young Investigator’s Award for Multiple Sclerosis Research
2004
Helmut-Bauer Award for Multiple Sclerosis Research
2002
Research scholarship, University of Göttingen